bammie schreef op 13 september 2019 18:43:
[...]
Citaat uit rapport First Berlin:
U.S. pre-eclampsia patient population is 20-30X larger than HAE population
In June Pharming received approval from the Dutch authorities to start a phase I/II trial of Ruconest with pre-eclampsia patients. There are 150,000 to 200,000 cases of pre-eclampsia in the U.S. every year. This compares with ca.
7,500 diagnosed U.S. HAE patients. (p.t.o.)
7.5k voor USA alleen